+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06444412

Evaluation of Ga-68 PSMA-11 PETCT Imaging to Detect Recurrence or Progression in Adults With High-Grade Glioma

Led by Mayo Clinic · Updated on 2026-06-22

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of gallium-68 Ga-68 prostate specific membrane antigen PSMA-11 PETCT imaging to help distinguish between glioma disease recurrence or progression and treatment effects in adults with WHO grade 3 or 4 gliomas. Glioma patients often undergo frequent imaging to assess disease status, but after initial treatment, it can be difficult to differentiate true tumor activity from treatment-related changes. This study aims to improve detection accuracy using Ga-68 PSMA-11 PETCT scans. Participants receive an intravenous injection of Ga-68 PSMA-11 followed by a combined PET and CT scan approximately 50 to 100 minutes later, lasting about one hour. The study focuses on the safety and feasibility of this imaging method, assessing adverse effects shortly after injection and tolerability over 60 days. Exploratory analyses compare PET uptake patterns with biopsy results and MRI images obtained clinically prior to enrollment. During the study, participants undergo the PETCT imaging procedure and planned biopsy or resection of suspected recurrent tumor. Researchers will collect tissue samples and review MRI scans to correlate imaging with pathology findings. Safety is monitored up to 24 hours after injection and tolerability up to 60 days. The total participation duration depends on scheduling of imaging and biopsy, with study completion expected by July 2028.

CONDITIONS

Brief Title

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

Research Team

C

Clinical Trials Referral Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here